OTC Markets OTCPK - Delayed Quote USD
PaxMedica, Inc. (PXMD)
At close: October 21 at 4:00 PM EDT
Research Analysis
Earnings Per Share
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 12/31/2023 | 3/31/2024 | |
|---|---|---|---|
| EPS Est. | -- | -0.88 | -0.43 |
| EPS Actual | -- | -1.45 | -0.5 |
| Difference | -- | -0.57 | -0.07 |
| Surprise % | -- | -64.80% | -16.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | -0.3 | -0.22 | -1.09 | 0 |
| 30 Days Ago | -0.3 | -0.22 | -1.09 | 0 |
| 60 Days Ago | -0.3 | -0.22 | -1.09 | 0 |
| 90 Days Ago | -0.3 | -0.22 | -1.09 | 0 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | PXMD | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 3.60% |
| Next Qtr. | -- | -- | -- | 7.90% |
| Current Year | -- | -- | -- | 2.50% |
| Next Year | -- | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.87% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Initiated | HC Wainwright & Co.: Buy | 12/4/2023 |
Related Tickers
KPRX Kiora Pharmaceuticals, Inc.
3.4900
+0.58%
VRAX Virax Biolabs Group Limited
1.6300
+6.54%
SPRC SciSparc Ltd.
0.2900
+26.53%
PALI Palisade Bio, Inc.
3.9100
+0.51%
CDIO Cardio Diagnostics Holdings, Inc.
0.2310
+9.53%
NRBO NeuroBo Pharmaceuticals, Inc.
2.9200
-3.63%
ENSC Ensysce Biosciences, Inc.
0.2060
+15.73%
QNRX Quoin Pharmaceuticals, Ltd.
0.8646
+1.72%
REVB Revelation Biosciences, Inc.
0.9034
-1.80%
ZVSA ZyVersa Therapeutics, Inc.
2.3000
0.00%